WNK2 and melanoma: The mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)-Akt are two of the most important signalling pathways in melanoma with growing evidence of their involvement in both melanoma initiation and therapeutic resistance [16].